Screening accuracy of Single-Point Insulin Sensitivity Estimator (SPISE) for metabolic syndrome: a systematic review and meta-analysis

Abstract Background Metabolic syndrome (MetS) is a multifactorial condition linked to increased risk of cardiovascular disease and type 2 diabetes. The Single-Point Insulin Sensitivity Estimator (SPISE), a non-invasive index calculated via 600 × HDL-C^0.185 / (TG^0.2 × BMI^1.338), offers a practical...

Полное описание

Библиографические подробности

Главные авторы:	Alireza Azarboo, Parisa Fallahtafti, Sayeh Jalali, Amirhossein Shirinezhad, Ramin Assempoor, Amirhossein Ghaseminejad-Raeini
Формат:	Artigo
Язык:	Inglês
Опубликовано:	BMC 2025-06-01
Серии:	BMC Endocrine Disorders
Предметы:	Metabolic syndrome Single-Point Insulin Sensitivity Estimator Insulin resistance Meta-analysis
Online-ссылка:	https://doi.org/10.1186/s12902-025-01957-6
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!